10:07 AM EST - Prometic Life Sciences Inc. : Will be presenting new data at the 2017 American Thoracic Society International Conference in Washington, D.C. showing the benefits of plasminogen administration in reducing lung injury in a gold standard animal model of Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) associated with acute pancreatitis. Prometic Life Sciences Inc.
shares T.PLI are trading up $0.01 at $2.02.
